Pregled bibliografske jedinice broj: 197227
Artificial reversion of acute myeloid leukemia cells into normal phenotype
Artificial reversion of acute myeloid leukemia cells into normal phenotype // International journal of biochemistry, 22 (1990), 5; 533-538 doi:10.1016/0020-711X(90)90269-9 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 197227 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Artificial reversion of acute myeloid leukemia cells into normal phenotype
Autori
Pavelić, Krešimir ; Baltić, Vladimir ; Spaventi, Šime
Izvornik
International journal of biochemistry (0020-711X) 22
(1990), 5;
533-538
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
acute myeloid leukemia ; cells
Sažetak
Induction of tumor cell differentiation could reverse transformed cells into normal, mature cells. Important question is whether these malignant-to-normal reversed cells are really normal ones. We have developed an experimental model based on the examination of three different levels of human acute myeloid leukemia cell properties before and after induction of differentiation: morphological (percentage of undifferentiated blast cells), functional (DNA ploidy, Fc receptors, phagocytic activity, clonogenic assay m soft agar, oxidative metabolism which accompanies phagocytosis in mature granulocytes) and genetical (expression of oncogene p53). Several inducers have been employed: dimethylsulfoxide (DMSO) granulocyte-macrophage colony stimulating factor (GM-CSF) ; tunicamycin, interferon gamma, tumor necrosis factor and lypopolysaccharide. Our results indicate that the reversion of leukemic cells into mature normal ones with some inducers (DMSO, GM-CSF) could be a complete process.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus